Premium
Nerve growth factor induced after temporomandibular joint inflammation decelerates chondrocyte differentiation
Author(s) -
Huang H,
Shank G,
Ma L,
Tallents RH,
Kyrkanides S
Publication year - 2013
Publication title -
oral diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.953
H-Index - 87
eISSN - 1601-0825
pISSN - 1354-523X
DOI - 10.1111/odi.12045
Subject(s) - chondrocyte , nerve growth factor , tropomyosin receptor kinase a , chondrogenesis , inflammation , osteoarthritis , microbiology and biotechnology , cellular differentiation , receptor , temporomandibular joint , medicine , chemistry , endocrinology , cartilage , pathology , biology , anatomy , biochemistry , alternative medicine , gene
Objective The goal of this study was to investigate changes in nerve growth factor ( NGF ) and its high‐affinity receptor‐tropomyosin receptor kinase A ( T rk A ) expression in the TMJ after intra‐articular inflammation. Materials and Methods We employed the C ol1‐ IL 1β XAT inducible model of joint inflammation. Changes in NGF and T rk A expression were evaluated by immunohistochemistry. The function of NGF on cell differentiation was assessed in vitro employing the ATDC 5 chondrocyte cell line. Results NGF expression was observed in articular chondrocytes only after TMJ inflammation, whereas TrkA expression was detected in articular chondrocytes under both naïve as well as inflamed conditions. The potential effect of NGF on articular chondrocytes was studied on the ATDC 5 cell line, whereby NGF decelerated the maturation rate of this chondrogenic cell line, presumably by arresting cell differentiation at the prehypertrophic stage of chondrocyte maturation. Conclusions NGF ‐TrkA signaling in the TMJ provides potentially a means of protection against the development of osteoarthritis by decelerating chondrocyte differentiation. This discovery may lead to the development of novel therapies for osteoarthritis of the TMJ and other joints.